Results 271 to 280 of about 5,782,005 (384)

CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy

VIEW, EarlyView.
Abstract Immuno‐oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification.
Yuhui Ma, Junxin Chen, Yuan Du, Zhihao Cao, Weizhi Ji, Yuyu Niu, Zebin Yang   +6 more
wiley   +1 more source

Current Anti-Myeloma Chimeric Antigen Receptor-T Cells: Novel Targets and Methods. [PDF]

Balkan Med J
Vural E, Beksaç M.
europepmc   +1 more source

Long‐term survival in a dog with suspected primary nodal plasmacytoma treated with surgical excision

Veterinary Record Case Reports, EarlyView.
Abstract An 8‐year‐old Staffordshire bull terrier presented for left submandibular lymphadenopathy. Cytology showed a monomorphic population of mature plasma cells suggestive of plasma cell neoplasia. On physical examination, no other lymphadenomegaly, cutaneous or oral lesions were found.
Celia Figueroa‐González, Jérémy Béguin, Sarah Stewart, Rachel Garty, Alexandra Guillén   +4 more
wiley   +1 more source

Revolutions at the frontline of multiple myeloma treatment: lessons and challenges to finding a cure. [PDF]

Front Oncol
Kort J, Rivera A, Senigarapu S, Driscoll JJ.   +3 more
europepmc   +1 more source

Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease [PDF]

, 2001
Sun Jin Choi, Yasuo Oba, Yair Gazitt, Melissa Alsina, Jose Cruz, Judith L. Anderson, G. David Roodman   +6 more
openalex   +1 more source

Biomarkers of Cellular Senescence in Type 2 Diabetes Mellitus

Aging Cell, EarlyView.
In cohorts of lean controls, obese participants without Type 2 Diabetes Mellitus (T2DM) and obese T2DM participants, we find that T‐cell expression of senescence biomarkers is altered only in the T2DM participants and not with obesity alone. Moreover, high T‐cell p16 expression in the T2DM participants is associated with impaired bone cortical indices.
Caroline Hoong, Joshua N. Farr, David G. Monroe, Thomas A. White, Elizabeth J. Atkinson, Amanda Tweed, Allyson K. Palmer, Nathan K. LeBrasseur, Jad G. Sfeir, Sundeep Khosla   +9 more
wiley   +1 more source

Transcriptional analysis of BMP2 and BMP6 in patients with newly diagnosed multiple myeloma. [PDF]

Oncol Lett
Stoikos P, Giannakoulas A, Kouvata E, Stefani G, Vassilopoulos G, Giannakoulas N.   +5 more
europepmc   +1 more source

Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease risk [PDF]

, 2001
Maurizio Chiriva‐Internati, Zhiqing Wang, Yuying Xue, Klaus Bumm, Amy B. Hahn, Seah H. Lim   +5 more
openalex   +1 more source

Zosteriform Primary Cutaneous Marginal Zone Lymphoma—A Case Report

Australasian Journal of Dermatology, EarlyView.
ABSTRACT We report a case of zosteriform PCMZL presenting in a T3–T4 dermatomal distribution not previously described in the literature. Although the varicella zoster virus was not detected in this case, late diagnosis of the acute eruption of zoster or even preceding zoster ‘sine herpete’ cannot be excluded as antigenic triggers.
Natalie Teh, Lachlan Byth, Victor Loh, Mrudula Krishnaswamy, Samuel Zagarella   +4 more
wiley   +1 more source

Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes. [PDF]

Int J Mol Sci
Sokołowski M, Łacina P, Bogunia-Kubik K, Mazur G, Butrym A.   +4 more
europepmc   +1 more source